Systematic Review of Intratympanic Gentamicin in Meniere's Disease

Journal of Otolaryngology

Volumn 32, Issue 6, 2003, Pages 351-361

  Diamond, Chris ^a   O'Connell, Daniel A ^a   Hornig, Joshua D ^a   Liu, Richard ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE   (Canada)

Author keywords

Hearing; Itratympanic gentamicin; Meniere's disease; Tinnitus; Vertigo

Indexed keywords

GENTAMICIN;

DISEASE EXACERBATION; DRUG EFFICACY; HEARING; HUMAN; MENIERE DISEASE; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TINNITUS; TREATMENT OUTCOME; VERTIGO;

EID: 1542349025     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2003.13863     Document Type: Review

References (79)

1. Meniere MP. Maladies de l'oreille interne offrant les symptoms de la congestion cerebrale apoplectiforme. Gaz Med Paris 1861; 16:55.
2. Nedzelski JM, Bryce GE, Pfleiderer AG. Treatment of Meniere's disease with topical gentamicin: a preliminary report. J Otolaryngol 1992; 21:95-101.
3. James AL, Burton MJ. Betahistine for Meniere's disease or syndrome (Cochrane Review). In: The Cochrane Library, Issue 4, 2001.
4. Slattery WH, Fayad JN. Medical treatment of Meniere's disease. Otolaryngol Clin North Am 1997; 30:1027-1037.
5. Grant IL, Welling DB. The treatment of hearing loss in Meniere's disease. Otolaryngol Clin North Am 1997; 30:1123-1144.
6. Fowler EP. Streptomycin treatment of vertigo. Trans Am Acad Ophthalmol Otolaryngol 1948; 52:239-301.
7. Schuknecht HF. Ablation therapy in the management of Meniere's disease. Acta Otolaryngol (Stockh) 1957; 132:3-42.
8. Beck C, Schmidt CL. 10 years of experience with intratympanally applied streptomycin (gentamycin) in the therapy of Morbus Meniere. Arch Otorhinolaryngol 1978; 221:149-152.
9. Lange G. Die intratympanale behandlung des Morbus Meniere mit ototoxichen antibiotica. Laryngorhinootologie 1977; 56:409-414.
10. Lange G. Gentamicin and other ototoxic antibodies for the transtympanic treatment of Meniere's disease. Arch Otorhinolaryngol 1989; 246:269-270.
11. Blakley BW. Clinical forum: a review of intratympanic therapy. Am J Otol 1997; 18:520-526.
12. Pensak ML, Bagger-Sjoback D, Shea JJ, et al. Clinical forum: a review of intratympanic therapy: invited comments. Am J Otol 1997; 18:527-531.
13. Blakley BW. Update on intratympanic gentamicin for Meniere's disease. Laryngoscope 2000; 110(2 Pt 1):236-240.
14. Brookes GB. The pharmacological treatment of Meniere's disease. Clin Otolaryngol 1996; 21:3-11.
15. Claes J, Van de Heyning PH. A review of medical treatment for Meniere's disease. Acta Otolaryngol Suppl (Stockh) 2000; 544:34-39.
16. Assimakopoulos D, Patrikakos G. Treatment of Meniere's disease by intratympanic gentamicin application. J Laryngol Otol 2003; 117:10-16.
17. Odkvist LM, Bergenius J, Moller C. When and how to use gentamicin in the treatment of Meniere's disease. Acta Otolaryngol Suppl (Stockh) 1997; 526:54-57.
18. Gustafson LM, Pensak ML. Inner ear perfusion therapy: an update. Curr Opin Otolaryngol Head Neck Surg 2000; 8:398-402.
19. Pearson BW, Brachmann DE. Committee on Hearing and Equilibrium guidelines for reporting treatment results in Meniere's disease. Otolaryngol Head Neck Surg 1985; 93:579-581.
20. Monsell EM, Balkany TA, Gates GA, et al. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 1995; 113:181-185.
21. Abou-Halawa AS, Poe DS. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Meniere's disease. Otol Neurotol 2002; 23:494-502.
22. Atlas JT, Parnes LS. Intratympanic gentamicin titration therapy for intractable Meniere's disease. Am J Otol 1999; 20:357-363.
23. Beck C. Intratympanic application of gentamicin for treatment of Meniere's disease. Kejo J Med 1986; 35:36-41.
24. Corsten M, Marsan J, Schramm D, Robichaud J. Treatment of intractable Meniere's disease with intratympanic gentamicin: review of the University of Ottawa experience. J Otolaryngol 1997; 26:361-364
25. Eklund S, Pyykko I, Aalto H, et al. Effect of intratympanic gentamicin on hearing and tinnitus in Meniere's disease. Am J Otol 1999; 20:350-356
26. Harner SG, Driscoll CLW, Facer GW, et al. Long-term follow-up of transtympanic gentamicin for Meniere's syndrome. Otol Neurotol 2001; 22:210-214.
27. Hirsch BE, Kamerer DB. Intratympanic gentamicin therapy for Meniere's disease. Am J Otol 1997; 18:44-51.
28. Inoue H, Uchi Y, Nogami K, Uemura T. Low-dose intratympanic gentamicin treatment of Meniere's disease. Eur Arch Otorhinolaryngol 1994; 251(Suppl 1):S12-S14.
29. Kaasinen S, Pyykko I, Ishizaki H, Aalto H. Intratympanic gentamicin in Meniere's disease. Acta Otolaryngol (Stockh) 1998; 118:294-298.
30. Kaplan DM, Nedzelski JM, Al-Abidi A, et al. Hearing loss following intratympanic instillation of gentamicin for the treatment of unilateral Meniere's disease. J Otolaryngol 2002; 31:106-111.
31. Laitakari K. Intratympanic gentamycin in severe Meniere's disease. Clin Otolaryngol 1990; 15:545-548.
32. Lange G. Transtympanic gentamycin in the treatment of Meniere's disease. Rev Laryngol Otol Rhinol 1995; 116:151-152.
33. Longridge NS, Mallinson AI. Low-dose intratympanic gentamicin treatment for dizziness in Meniere's disease. J Otolaryngol 2000; 29:35-39.
34. Magnusson M, Padoan S. Delayed onset of ototoxic effects of gentamicin in treatment of Meniere's disease. Rationale for extremely low dose therapy. Acta Otolaryngol (Stockh) 1991; 111:671-676.
35. Marzo SJ, Leonetti JP. Intratympanic gentamicin therapy for persistent vertigo after endolymphatic sac surgery. Otolaryngol Head Neck Surg 2002; 126:31-33.
36. McFeely WJ, Singleton GT, Rodriguez FJ, Antonelli PJ. Intratympanic gentamicin treatment for Meniere's disease. Otolaryngol Head Neck Surg 1998; 118:589-596.
37. Minor LB. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Am J Otol 1999; 20:209-219.
38. Murofushi T, Halmagyi GM, Yavor RA. Intratympanic gentamicin in Meniere's disease: results of therapy. Am J Otol 1997; 18:52-57.
39. Odkvist LM. Pressure treatment versus gentamicin for Meniere's disease. Acta Otolaryngol (Stockh) 2001; 121:266-268.
40. Odkvist LM. Middle ear ototoxic treatment for inner ear disease. Acta Otolaryngol Suppl (Stockh) 1988; 457:83-86.
41. Perez N, Martin E, Zubieta JL, et al. Benign paroxysmal positional vertigo in patients with Meniere's disease treated with intratympanic gentamycin. Laryngoscope 2002; 112:1104-1109.
42. Pfleiderer AG. The current role of local intratympanic gentamicin therapy in the management of unilateral Meniere's disease. Clin Otolaryngol 1998; 23:34-41.
43. Quaranta A, Aloisi A, De Benedittis G, Scaringi A. Intratympanic therapy for Meniere's disease. High-concentration gentamicin with round-window protection. Ann N Y Acad Sci 1999; 884:410-424.
44. Quaranta A, Scaringi A, Aloisi A, et al. Intratympanic therapy for Meniere's disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol (Stockh) 2001; 121:387-392.
45. Rauch SD, Oas JG. Intratympanic gentamicin for treatment of intractable Meniere's disease: a preliminary report. Laryngoscope 1997; 107:49-55.
46. Sala T. Transtympanic administration of aminoglycosides in patients with Meniere's disease. Arch Otorhinolaryngol 1988; 245:293-296.
47. Sala T. Transtympanic gentamicin in the treatment of Meniere's disease. Auris Nasus Larynx 1997; 24:239-246.
48. Schoendorf J, Neugebauer P, Michel O. Continuous intratympanic infusion of gentamicin via a microcatheter in Meniere's disease. Otolaryngol Head Neck Surg 2001; 124:203-207.
49. Sennaroglu L, Sennaroglu G, Gursel B, Dini FM. Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere's disease. Otolaryngol Head Neck Surg 2001; 125:537-543.
50. Silverstein H, Arruda J, Rosenberg SI, et al. Direct round window membrane application of gentamicin in the treatment of Meniere's disease. Otolaryngol Head Neck Surg 1999; 120:649-655.
51. Thomsen J, Charabi S, Tos M. Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere's disease. Eur Arch Otorhinolaryngol 2000; 257:362-365.
52. Toth AA, Parnes LS. Intratympanic gentamicin therapy for Meniere's disease: preliminary comparison of two regimens. J Otolaryngol 1995; 24:340-344.
53. Watanabe S, Kato I, Takahashi K, et al. Indications and results of gentamicin injection into the middle ear of patients with Meniere's disease. Acta Otolaryngol Suppl (Stockh) 1995; 519:282-285.
54. Yamazaki T, Hayashi M, Komatsuzaki A. Intratympanic gentamicin therapy for Meniere's disease placed by a tubal catheter with systematic isosorbide. Acta Otolaryngol Suppl (Stockh) 1991; 481:613-616.
55. Yetiser S, Kertmen M. Intratympanic gentamicin in Meniere's disease: the impact on tinnitus. Int J Audiol 2002; 41:363-370.
56. Hone SW, Nedzelski J, Chen J. Does intratympanic gentamicin treatment for Meniere's disease cause complete vestibular ablation? J Otolaryngol 2000; 29:83-87.
57. Pender DJ. Gentamicin tympanoclysis: effects on the vestibular secretory cells. Am J Otolaryngol 1985; 6:358-367.
58. Park CJ, Cohen GM. Vestibular ototoxicity in the chick: effects of streptomycin on equilibrium and on ampullary dark cells. Am J Otolaryngol 1982; 3:117-127.
59. Adamonis J, Stanton SG, Cashman MZ, et al. Electrocochleography and gentamicin therapy for Meniere's disease: a preliminary report. Am J Otol 2000; 21:534-542.
60. Nakashima T, Teranishi M, Hibi T, et al. Vestibular and cochlear toxicity of aminoglycosides - a review. Acta Otolaryngol (Stockh) 2000; 120:904-911.
61. Becvarovski Z, Bojrab DI, Michaelides EM, et al. Round window getamicin absorption: an in vivo human model. Laryngoscope 2002; 112:1610-1613
62. Silverstein H, Rowan PT, Olds MJ, Rosenberg SI. Inner ear perfusion and the role of round window patency. Am J Otol 1997; 18:586-589.
63. Plontke S, Zenner HP. Pharmacokinetic considerations in intratympanic drug delivery to the inner ear. Acta Otorhinolaryngol Belg 2002; 56:369-370.
64. Brantberg K, Bergenius J, Tribukait A. Gentamicin treatment in peripheral vestibular disorders other than Meniere's disease. ORL J Otorhinolaryngol Relat Spec 1996; 58:277-279.
65. Odkvist L. Pressure treatment versus gentamicin for Meniere's disease. Acta Otolaryngol (Stockh) 2001; 121:266-268.
66. Soderman AC, Bergenius J, Bagger-Sjoback D, et al. Patients' subjective evaluations of quality of life related to disease-specific symptoms, sense of coherence, and treatment in Meniere's disease. Otol Neurotol 2001; 22:526-533.
67. Youssef TF, Poe DS. Intratympanic gentamicin injection for the treatment of Meniere's disease. Am J Otol 1998; 19:435-442.
68. Parnes LS, Riddell D. Irritative spontaneous nystagmus following intratympanic gentamicin for Meniere's disease. Laryngoscope 1993; 103:745-749.
69. Kaasinen S, Pyykko I, Ishizaki H, Aalto H. Effect of intratympanically administered gentamicin on hearing and tinnitus in Meniere's disease. Acta Otolaryngol Suppl (Stockh) 1995; 520(Pt 1):184-185.
70. Pyykko I, Ishizaki H, Kaasinen S, Aalto H. Intratympanic gentamicin in bilateral Meniere's disease. Otolaryngol Head Neck Surg 1994; 110:162-167.
71. Harner SG, Kasperbauer JL, Facer GW, Beatty CW. Transtympanic gentamicin for Meniere's syndrome. Laryngoscope 1998; 108:1446-1449.
72. Driscoll CLW, Kasperbauer JL, Facer GW, et al. Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results. Laryngoscope 1997; 107:83-89.
73. Kaplan DM, Nedzelski JM, Chen JM, Shipp DB. Intratympanic gentamicin for the treatment of unilateral Meniere's disease. Laryngoscope 2000; 110:1298-1305.
74. Nedzelski JM, Chiong CM, Fradet G, et al. Intratympanic gentamicin instillation as treatment of unilateral Meniere's disease: update of an ongoing study. Am J Otol 1993; 14:278-282.
75. Nedzelski JM, Schessel DA, Bryce GE, Pfleiderer AG. Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Meniere's disease. Am J Otol 1992; 13:18-22.
76. Magnusson M, Padoan S, Karlberg M, Johansson R. Delayed onset of ototoxic effects of gentamicin in patients with Meniere's disease. Acta Otolaryngol Suppl (Stockh) 1991; 485:120-122.
77. Carey JP, Minor LB, Peng GCY, et al. Changes in the three-dimensional angular vestibulo-ocular reflex following intratympanic gentamicin for Meniere's disease. JARO 2002; 3:430-443.
78. Moller C, Odkvist LM, Thell J, et al. Vestibular and audiologic functions in gentamicin-treated Meniere's disease. Am J Otol 1988; 9:383-391.
79. Yamazaki T, Hayashi M, Hayashi N, Kozaki H. Intratympanic gentamicin therapy for Meniere's disease placed by tubal catheter with systemic isosorbide. Arch Otorhinolaryngol 1988; 245:170-174.